Symbols / TTOO $0.00 +0.00% T2 Biosystems, Inc.

Healthcare • Diagnostics & Research • United States • PNK
TTOO Chart
About

T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel. The company was incorporated in 2006 and is based in Lexington, Massachusetts.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Diagnostics & Research Market Cap 5.61K
Enterprise Value 16.87M Income -42.95M Sales 7.68M
Book/sh -0.62 Cash/sh 0.10 Dividend Yield —
Payout 0.00% Employees 113 IPO —
P/E — Forward P/E -0.00 PEG —
P/S 0.00 P/B -0.00 P/C —
EV/EBITDA -0.41 EV/Sales 2.20 Quick Ratio 0.17
Current Ratio 0.40 Debt/Eq — LT Debt/Eq —
EPS (ttm) -0.03 EPS next Y -1.19 EPS Growth —
Revenue Growth 34.90% Earnings 2025-06-11 16:00 ROA -84.85%
ROE — ROIC — Gross Margin -247.83%
Oper. Margin -5.12% Profit Margin 0.00% Shs Outstand 28.05M
Shs Float 11.90M Short Float 4.87% Short Ratio 0.71
Short Interest — 52W High 0.18 52W Low 0.00
Beta 1.24 Avg Volume 9.79K Volume 35.00
Target Price — Recom None Prev Close $0.00
Price $0.00 Change 0.00%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.00
Latest analyst target
3. DCF / Fair value
$-16.92
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.00
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2024-07-30 main Canaccord Genuity Hold → Hold $5
2024-04-29 main Canaccord Genuity Hold → Hold $3
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2024-09-13 ELSBREE DAVID B Director — 55 $2.42 $133
2024-05-09 CR GROUP, L.P. Beneficial Owner of more than 10% of a Class of Security — 1,824,800 — —
2024-05-03 CR GROUP, L.P. Beneficial Owner of more than 10% of a Class of Security — 4,748,335 $0.00 $0
2024-04-12 CR GROUP, L.P. Beneficial Owner of more than 10% of a Class of Security — 3,280,618 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2023-12-31 2022-12-31 2021-12-31
Total Revenue
7.19
-67.75%
22.30
-20.50%
28.06
Operating Revenue
7.19
-67.75%
22.30
-20.50%
28.06
Cost Of Revenue
15.36
-26.88%
21.01
+1.48%
20.70
Reconciled Cost Of Revenue
15.36
-26.88%
21.01
+1.48%
20.70
Gross Profit
-8.17
-730.89%
1.29
-82.39%
7.36
Operating Expense
38.98
-30.81%
56.34
+11.95%
50.33
Research And Development
14.15
-44.96%
25.71
+17.95%
21.80
Selling General And Administration
24.83
-18.92%
30.62
+7.35%
28.53
Total Expenses
54.35
-29.74%
77.35
+8.90%
71.03
Operating Income
-47.15
+14.34%
-55.05
-28.09%
-42.97
Total Operating Income As Reported
-49.66
+10.02%
-55.20
-28.44%
-42.97
EBITDA
-43.88
+20.04%
-54.87
-40.31%
-39.11
Normalized EBITDA
-46.79
+13.29%
-53.96
-34.50%
-40.12
Reconciled Depreciation
0.86
-17.96%
1.05
-58.75%
2.54
EBIT
-44.73
+20.00%
-55.92
-34.28%
-41.65
Total Unusual Items
2.91
+419.17%
-0.91
-190.40%
1.01
Total Unusual Items Excluding Goodwill
2.91
+419.17%
-0.91
-190.40%
1.01
Special Income Charges
-2.51
-1562.91%
-0.15
—
Impairment Of Capital Assets
2.51
+1562.91%
0.15
—
Net Income
-50.08
+19.23%
-62.00
-25.92%
-49.24
Pretax Income
-50.08
+19.23%
-62.00
-25.92%
-49.24
Net Non Operating Interest Income Expense
-5.34
+12.18%
-6.08
+18.71%
-7.48
Interest Expense Non Operating
5.34
-12.18%
6.08
-19.91%
7.60
Net Interest Income
-5.34
+12.18%
-6.08
+18.71%
-7.48
Interest Expense
5.34
-12.18%
6.08
-19.91%
7.60
Interest Income Non Operating
—
0.01
-92.86%
0.11
Interest Income
—
0.01
-92.86%
0.11
Other Income Expense
2.42
+376.77%
-0.87
-171.88%
1.22
Other Non Operating Income Expenses
-0.49
-1369.23%
0.04
-81.07%
0.21
Gain On Sale Of Security
5.42
+811.94%
-0.76
-175.45%
1.01
Tax Rate For Calcs
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-50.08
+19.23%
-62.00
-25.92%
-49.24
Net Income From Continuing Operation Net Minority Interest
-50.08
+19.23%
-62.00
-25.92%
-49.24
Net Income From Continuing And Discontinued Operation
-50.08
+19.23%
-62.00
-25.92%
-49.24
Net Income Continuous Operations
-50.08
+19.23%
-62.00
-25.92%
-49.24
Normalized Income
-52.99
+13.26%
-61.09
-21.57%
-50.25
Net Income Common Stockholders
-50.08
+19.66%
-62.33
-26.59%
-49.24
Diluted EPS
-19.19
+98.44%
-1,228.00
-3861.29%
-31.00
Basic EPS
-19.19
+98.44%
-1,228.00
-3861.29%
-31.00
Basic Average Shares
2.61
+5017.31%
0.05
-96.79%
1.59
Diluted Average Shares
2.61
+5017.31%
0.05
-96.79%
1.59
Diluted NI Availto Com Stockholders
-50.08
+19.66%
-62.33
-26.59%
-49.24
Preferred Stock Dividends
—
0.33
—
Line Item Trend 2023-12-31 2022-12-31 2021-12-31
Total Assets
34.80
+1.37%
34.33
-43.30%
60.54
Current Assets
25.19
+30.12%
19.36
-56.39%
44.39
Cash Cash Equivalents And Short Term Investments
15.69
+51.89%
10.33
-67.96%
32.24
Cash And Cash Equivalents
15.69
+51.89%
10.33
-53.57%
22.25
Other Short Term Investments
—
0.00
-100.00%
10.00
Receivables
1.42
-34.35%
2.16
-57.87%
5.13
Accounts Receivable
1.42
-34.35%
2.16
-57.87%
5.13
Gross Accounts Receivable
1.52
-32.83%
2.26
-55.92%
5.13
Allowance For Doubtful Accounts Receivable
-0.10
+0.00%
-0.10
—
Inventory
4.82
+12.46%
4.29
+9.62%
3.91
Raw Materials
1.88
-6.14%
2.00
+25.96%
1.59
Work In Process
1.44
+22.53%
1.18
+23.40%
0.95
Finished Goods
1.50
+35.48%
1.10
-19.05%
1.36
Prepaid Assets
—
—
3.11
Other Current Assets
3.26
+26.30%
2.58
-16.98%
3.11
Total Non Current Assets
9.61
-35.81%
14.97
-7.29%
16.14
Net PPE
9.05
-31.80%
13.27
-8.08%
14.44
Gross PPE
23.90
-13.17%
27.53
-6.41%
29.42
Accumulated Depreciation
-14.85
-4.17%
-14.26
+4.81%
-14.98
Properties
0.00
0.00
0.00
Machinery Furniture Equipment
1.69
-2.94%
1.74
+0.46%
1.73
Construction In Progress
0.02
-96.64%
0.69
+33.79%
0.51
Other Properties
18.59
-12.84%
21.32
-8.90%
23.41
Leases
3.61
-4.65%
3.78
+0.42%
3.77
Investments And Advances
—
—
0.00
Other Non Current Assets
0.56
-67.24%
1.69
-0.59%
1.70
Total Liabilities Net Minority Interest
62.83
-15.07%
73.98
+0.74%
73.44
Current Liabilities
56.15
+454.42%
10.13
-13.35%
11.69
Payables And Accrued Expenses
11.24
+31.22%
8.56
-14.32%
10.00
Payables
1.53
+17.82%
1.30
-54.24%
2.83
Accounts Payable
1.53
+17.82%
1.30
-54.24%
2.83
Current Accrued Expenses
9.71
+33.61%
7.27
+1.47%
7.16
Current Debt And Capital Lease Obligation
42.90
+3073.08%
1.35
+15.16%
1.17
Current Debt
41.28
—
—
Other Current Borrowings
41.28
—
—
Current Capital Lease Obligation
1.62
+19.53%
1.35
+15.16%
1.17
Current Deferred Liabilities
0.22
+30.23%
0.17
-66.80%
0.52
Current Deferred Revenue
0.22
+30.23%
0.17
-66.80%
0.52
Other Current Liabilities
1.79
+4487.18%
0.04
—
Total Non Current Liabilities Net Minority Interest
6.68
-89.54%
63.85
+3.40%
61.75
Long Term Debt And Capital Lease Obligation
6.60
-88.60%
57.87
+1.25%
57.15
Long Term Debt
—
49.65
+3.89%
47.79
Long Term Capital Lease Obligation
6.60
-19.67%
8.21
-12.23%
9.36
Non Current Deferred Liabilities
0.08
+59.62%
0.05
+85.71%
0.03
Non Current Deferred Revenue
0.08
+59.62%
0.05
+85.71%
0.03
Other Non Current Liabilities
—
4.85
+5.94%
4.58
Stockholders Equity
-28.04
+29.30%
-39.66
-207.33%
-12.90
Common Stock Equity
-28.04
+29.30%
-39.66
-207.33%
-12.90
Capital Stock
0.00
0.00
-100.00%
0.00
Common Stock
0.00
0.00
-100.00%
0.00
Preferred Stock
0.00
0.00
0.00
Share Issued
4.06
+5159.35%
0.08
-95.36%
1.66
Ordinary Shares Number
4.06
+5159.35%
0.08
-95.36%
1.66
Additional Paid In Capital
556.26
+12.47%
494.56
+7.67%
459.31
Retained Earnings
-584.30
-9.37%
-534.22
-13.13%
-472.22
Gains Losses Not Affecting Retained Earnings
—
0.00
+100.00%
-0.00
Total Equity Gross Minority Interest
-28.04
+29.30%
-39.66
-207.33%
-12.90
Total Capitalization
-28.04
-380.47%
10.00
-71.35%
34.89
Working Capital
-30.96
-435.42%
9.23
-71.78%
32.71
Invested Capital
13.25
+32.53%
10.00
-71.35%
34.89
Total Debt
49.50
-16.41%
59.22
+1.53%
58.32
Net Debt
25.59
-34.91%
39.32
+53.93%
25.55
Capital Lease Obligations
8.21
-14.13%
9.57
-9.18%
10.53
Net Tangible Assets
-28.04
+29.30%
-39.66
-207.33%
-12.90
Tangible Book Value
-28.04
+29.30%
-39.66
-207.33%
-12.90
Derivative Product Liabilities
0.00
-100.00%
1.09
0.00
Interest Payable
0.84
-16.85%
1.01
+3.59%
0.97
Investmentin Financial Assets
—
—
0.00
Non Current Accrued Expenses
0.00
-100.00%
4.85
—
Line Item Trend 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-48.14
+4.92%
-50.63
-30.24%
-38.87
Cash Flow From Continuing Operating Activities
-48.14
+4.92%
-50.63
-30.24%
-38.87
Net Income From Continuing Operations
-50.08
+19.23%
-62.00
-25.92%
-49.24
Depreciation Amortization Depletion
0.86
-17.96%
1.05
-58.75%
2.54
Depreciation
—
2.27
-10.52%
2.54
Depreciation And Amortization
0.86
-17.96%
1.05
-58.75%
2.54
Other Non Cash Items
3.68
+9.74%
3.36
-14.67%
3.93
Stock Based Compensation
4.35
-32.99%
6.49
-8.42%
7.09
Asset Impairment Charge
2.51
+1562.91%
0.15
0.00
Operating Gains Losses
-5.42
-754.04%
0.83
+180.96%
-1.02
Gain Loss On Investment Securities
-5.42
-754.40%
0.83
+180.96%
-1.02
Gain Loss On Sale Of PPE
0.00
0.00
0.00
Change In Working Capital
-4.04
-703.58%
-0.50
+76.83%
-2.17
Change In Receivables
0.74
-74.99%
2.97
+8588.57%
-0.04
Changes In Account Receivables
0.74
-74.99%
2.97
+8588.57%
-0.04
Change In Inventory
-0.74
+21.60%
-0.95
+51.08%
-1.94
Change In Prepaid Assets
-0.55
-216.77%
0.47
+200.86%
-0.47
Change In Payables And Accrued Expense
-2.22
-70.27%
-1.30
-185.29%
1.53
Change In Accrued Expense
-2.45
-1039.85%
0.26
-66.06%
0.77
Change In Payable
0.23
+114.75%
-1.57
-305.78%
0.76
Change In Account Payable
0.23
+114.75%
-1.57
-305.78%
0.76
Change In Other Working Capital
0.08
+125.78%
-0.32
-198.15%
-0.11
Change In Other Current Liabilities
-1.35
+1.24%
-1.37
-18.94%
-1.15
Investing Cash Flow
-0.19
-101.99%
9.66
-61.04%
24.79
Cash Flow From Continuing Investing Activities
-0.19
-101.99%
9.66
-61.04%
24.79
Net PPE Purchase And Sale
-0.19
+43.36%
-0.34
+26.30%
-0.46
Purchase Of PPE
-0.19
+43.36%
-0.34
+26.30%
-0.46
Sale Of PPE
—
—
0.00
Capital Expenditure
-0.19
+43.36%
-0.34
+26.30%
-0.46
Net Investment Purchase And Sale
0.00
-100.00%
10.00
-60.41%
25.25
Purchase Of Investment
—
—
0.00
Sale Of Investment
0.00
-100.00%
10.00
-60.41%
25.25
Financing Cash Flow
52.69
+81.35%
29.05
+41.49%
20.54
Cash Flow From Continuing Financing Activities
52.69
+81.35%
29.05
+41.49%
20.54
Net Common Stock Issuance
52.73
+80.82%
29.16
+46.04%
19.97
Repurchase Of Capital Stock
0.00
+100.00%
-0.33
0.00
Proceeds From Stock Option Exercised
0.02
-88.48%
0.17
-70.90%
0.57
Net Other Financing Charges
-0.06
+74.49%
-0.24
—
Changes In Cash
4.36
+136.59%
-11.92
-284.69%
6.45
Beginning Cash Position
11.88
-50.08%
23.80
+37.20%
17.34
End Cash Position
16.24
+36.70%
11.88
-50.08%
23.80
Free Cash Flow
-48.33
+5.18%
-50.97
-29.58%
-39.33
Interest Paid Supplemental Data
3.86
-1.46%
3.92
+2.70%
3.81
Common Stock Issuance
52.73
+80.82%
29.16
+46.04%
19.97
Issuance Of Capital Stock
52.73
+78.98%
29.46
+47.55%
19.97
Net Preferred Stock Issuance
0.00
+100.00%
-0.03
0.00
Preferred Stock Issuance
0.00
-100.00%
0.30
0.00
Preferred Stock Payments
0.00
+100.00%
-0.33
0.00
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category